Cytokines and chemokines expression in serum of patients with neuromyelitis optica

References

• HickmanSJKoMChaudhryFJayWMPlantGTOptic neuritis: an update typical and atypical optic neuritisNeuroophthalmology2008325237248
   Web of Science ®Google Scholar
• ShamsPNPlantGTOptic neuritis: a reviewInt MS J2009163828919878630
   PubMedGoogle Scholar
• InnisMDLandyPJOptic neuritis and multiple sclerosisLancet1979314813252
   Google Scholar
• MinLXin-YueQThe clinical application of a variety of methods to detect AQP4-Ab in serum and cerebrospinal fluid of neuromyelitis optica patientsChin J Lab Diagn2015812611263
   Google Scholar
• TingLDaqiZChunshengYHuiZThe significance of serum aquaporin 4 antibody in the spectrum of optic neuromyelitisShandong Med J2015175253
   Google Scholar
• WingerchukDMLennonVAPittockSJLucchinettiCFWeinshenkerBGRevised diagnostic criteria for neuromyelitis opticaDigest World Core Med J200666101485
   Google Scholar
• JariusSWildemannBAquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literatureBrain Pathol201323666168324118483
   PubMed Web of Science ®Google Scholar
• JariusSPaulFFechnerKAquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrateJ Neuroinflammation201411112925074611
   PubMed Web of Science ®Google Scholar
• MaderSGredlerVSchandaKComplement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disordersJ Neuroinflammation20118118422204662
   PubMed Web of Science ®Google Scholar
• MartaCBTaylorCMCoetzeeTAntibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphologyJ Neurosci200323135461547112843245
   PubMed Web of Science ®Google Scholar
• DaleRCTantsisEMMerhebVAntibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonNeurol Neuroimmunol Neuroinflamm201411e1225340056
   PubMedGoogle Scholar
• PiddlesdenSJLassmannHZimprichFMorganBPLiningtonCThe demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complementAm J Pathol1991352555
   Google Scholar
• MayerMCMeinlEGlycoproteins as targets of autoantibodies in CNS inflammation: MOG and moreTher Adv Neurol Disord20125314715922590479
   PubMed Web of Science ®Google Scholar
• JariusSWildemannBPaulFNeuromyelitis optica: clinical features, immunopathogenesis and treatmentClin Exp Immunol2014176214916424666204
   PubMed Web of Science ®Google Scholar
• LucchinettiCFMandlerRNMcGavernDA role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis opticaBrain2002125Pt 71450146112076996
   PubMed Web of Science ®Google Scholar
• MitsdoerfferMKuchrooVKornTImmunology of neuromyelitis optica: a T cell-B cell collaborationAnn N Y Acad Sci201312831576623617588
   PubMed Web of Science ®Google Scholar
• UzawaAMoriMAraiKCytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6Mult Scler201016121443145220739337
   PubMed Web of Science ®Google Scholar
• MatsushitaTTateishiTIsobeNCharacteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosisPLoS One201384e6183523637915
   PubMed Web of Science ®Google Scholar
• TanakaMMatsushitaTTateishiTDistinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitisNeurology2008711397498118809833
   PubMed Web of Science ®Google Scholar
• UzawaAMoriMItoMMarkedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosisJ Neurol2009256122082208419655191
   PubMed Web of Science ®Google Scholar
• XiaonanZHonghaoWYongqiangDCerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis opticaJ Neuroimmunol2011240–241104108
   Web of Science ®Google Scholar
• AlvarezEPiccioLMikesellRJCXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditionsMult Scler20131991204120823322500
   PubMed Web of Science ®Google Scholar
• WangHWangKZhongXCerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapseJ Clin Immunol20123251007101122644841
   PubMed Web of Science ®Google Scholar
• BoveRElsoneLAlvarezEFemale hormonal exposures and neuromyelitis optica symptom onset in a multicenter studyNeurol Neuroimmunol Neuroinflamm201743e33928382320
   PubMed Web of Science ®Google Scholar
• MarignierRBernard-ValnetRGiraudonPAquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entityNeurology201380242194220023658379
   PubMed Web of Science ®Google Scholar
• JiaoYFryerJPLennonVAUpdated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis opticaNeurology201381141197120423997151
   PubMed Web of Science ®Google Scholar
• LevyMDoes aquaporin-4-seronegative neuromyelitis optica exist?JAMA Neurol201471327127224424919
   PubMed Web of Science ®Google Scholar
• WatersPJMcKeonALeiteMISerologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assaysNeurology201278966567122302543
   PubMed Web of Science ®Google Scholar
• JariusSPaulFFranciottaDNeuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literatureMult Scler20121881135114322183934
   PubMed Web of Science ®Google Scholar
• JariusSWildemannBThe history of neuromyelitis opticaJ Neuroinflammation201310111223282009
   PubMed Web of Science ®Google Scholar
• BradlMMisuTTakahashiTNeuromyelitis optica: pathogenicity of patient immunoglobulin in vivoAnn Neurol200966563064319937948
   PubMed Web of Science ®Google Scholar
• FujiharaKLeiteMISeronegative NMO: a sensitive AQP4 antibody test clarifies clinical features and next challengesNeurology201380242176217723658387
   PubMed Web of Science ®Google Scholar
• FujiharaKMisuTAQP4 in biopsied demyelinating lesions as a diagnostic clue to NMOSD and MS: final answer?Neurology201584211011125503619
   PubMed Web of Science ®Google Scholar
• JariusSRuprechtKKleiterIMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and originJ Neuroinflammation201613127927788675
   PubMed Web of Science ®Google Scholar
• YaoHPengYTongJClinical significance of midkine expression in gestational trophoblastic diseaseJ Med Res2014438127130
   Google Scholar